• Hematology
  • Clinicals

Hemochromatosis: Causes, Symptoms, Diagnosis and Treatment

  • Reading time: 2 minutes, 49 seconds
  • 1407 Views
  • Updated on: 2025-05-22 11:26:54

Hemochromatosis refers to a group of conditions characterized by excessive iron accumulation in parenchymal tissues , leading to progressive organ damage due to iron-induced oxidative stress .

It is the most common autosomal recessive disorder in individuals of Northern European descent and a leading cause of severe iron overload .

Etiology and Classification

Hemochromatosis can be hereditary or acquired .

A. Hereditary Hemochromatosis (HH)

Characterized by increased intestinal iron absorption due to genetic mutations, leading to systemic iron overload.

Type Gene Involved Inheritance Key Features
Type 1 (Classic HH) HFE (C282Y and H63D mutations) Autosomal recessive Most common form
Type 2A (Juvenile) HJV (hemojuvelin) Autosomal recessive Presents before age 30
Type 2B HAMP (hepcidin gene) Autosomal recessive Severe early onset
Type 3 TFR2 (transferrin receptor 2) Autosomal recessive Less common
Type 4 (Ferroportin disease) SLC40A1 (ferroportin) Autosomal dominant May cause macrophage iron accumulation

 

B. Acquired Iron Overload

Includes:

  • Chronic transfusions (e.g., thalassemia major, sickle cell anemia)
  • Sideroblastic anemia
  • Chronic liver disease
  • Iron-loading anemias

Pathophysiology

  • Normal iron stores : ~3.5 g in men; ~2.5 g in women
  • Toxicity develops when iron stores exceed ~10 g
  • Iron is absorbed via the duodenum , primarily regulated by hepcidin , a liver-produced hormone
  • Hepcidin suppresses ferroportin , an iron transporter; mutations in HFE , hemojuvelin , or hepcidin result in reduced hepcidin levels , increasing iron absorption

Organ Damage Mechanism:

  • Excess iron catalyzes formation of free hydroxyl radicals (Fenton reaction)
  • Oxidative damage to cellular components leads to:
    • Liver fibrosis and cirrhosis
    • Pancreatic β-cell dysfunction (diabetes mellitus)
    • Cardiomyopathy
    • Pituitary and gonadal failure
    • Joint degeneration

Clinical Features

Most patients are asymptomatic in early stages (≈75%).

Early Non-Specific Symptoms:

  • Fatigue (most common, ~74%)
  • Arthralgia , especially of hands (44%)
  • Impotence or decreased libido (~45%)
  • "Iron Fist" : Pain in the 2nd and 3rd MCP joints (knuckles)—a specific early sign

Advanced Organ-Specific Manifestations:

Organ Manifestations
Liver Hepatomegaly, elevated LFTs, fibrosis, cirrhosis, ↑HCC risk
Pancreas Diabetes mellitus ("bronze diabetes")
Heart Restrictive or dilated cardiomyopathy, arrhythmias
Skin Hyperpigmentation (bronze or gray skin)
Gonads Hypogonadotropic hypogonadism, infertility
Joints Chronic arthropathy (often confused with RA)

 

Diagnosis

Initial Screening:

  • Transferrin saturation (TS%) : >45% is suggestive
  • Serum ferritin : >300 ng/mL in men; >200 ng/mL in women
    (Note: Elevated ferritin also occurs in inflammation and liver disease)

Confirmatory Testing:

  • HFE gene testing for C282Y and H63D mutations
  • Liver biopsy : if diagnosis is unclear or if assessing fibrosis
  • MRI : to assess liver and cardiac iron concentration

Management

1. Phlebotomy (Therapeutic Venesection)

  • Mainstay of treatment
  • Weekly removal of 500 mL blood until ferritin <50 ng/mL
  • Maintenance phlebotomy every 3–4 months thereafter
  • Benefits: Prevents or slows cirrhosis, improves fatigue and skin changes
  • Limitations: Does not prevent hepatocellular carcinoma (HCC)

2. Iron Chelation Therapy

  • Used in patients unable to undergo phlebotomy
  • Agents: Deferoxamine , Deferasirox

3. Lifestyle and Dietary Recommendations

  • Avoid iron supplements , vitamin C supplements (enhance absorption)
  • Moderate alcohol use—excessive alcohol potentiates liver damage
  • Avoid uncooked seafood (risk of Vibrio vulnificus infection)

4. Monitoring

  • Routine follow-up with serum ferritin , transferrin saturation
  • Liver ultrasound or AFP screening for HCC in cirrhotic patients

High-Yield Facts

  • Most specific symptom : Pain in the 2nd and 3rd MCP joints ("Iron Fist")
  • Best initial test : Transferrin saturation
  • Most accurate test : Genetic testing for HFE mutations
  • Definitive treatment : Regular phlebotomy
  • Risk of HCC : Persists even after iron depletion in cirrhotic patients

Mnemonic: “IRON FIST”

I : Increased iron
R : Restrictive cardiomyopathy
O : Organ damage (pancreas, liver, pituitary)
N : Noticed skin (bronze)
F : Fatigue
I : Impotence
S : Second and third MCP pain
T : Transferrin saturation ↑


Article Details

Free Plan article
  • Clinicals
  • Hematology
  • 0.50 Points
  • Free
About The Author
author

Dan Ogera

Chief Editor

Most Popular Posts

Slide Presentations